Compass Pathways PLC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Director Daphne Karydas was granted 21,110 stock options in COMPASS Pathways plc as part of standard equity compensation.
NASDAQ
Director Gino Santini was granted 30,158 share options in COMPASS Pathways plc as part of an equity compensation arrangement.
NASDAQ
Director Justin Gover was granted 21,110 share options in COMPASS Pathways plc as part of a standard equity compensation arrangement.
NASDAQ
Director Jeffrey M. Jonas was granted 21,110 stock options in COMPASS Pathways plc as part of a standard equity compensation award.
NASDAQ
COMPASS Pathways plc director Wayne Riley was granted 21,110 stock options as part of standard equity compensation.
NASDAQ
Director Robert McQuade was granted 21,110 share options in COMPASS Pathways plc as part of an equity compensation award.
NASDAQ
Director David Norton was granted 21,110 share options in COMPASS Pathways plc as part of standard equity compensation.
NASDAQ
Compass Pathways director Kathleen Tregoning was granted 41,119 stock options as part of a standard equity compensation package.
NASDAQ
COMPASS Pathways plc CEO Kabir Nath acquired 175,000 Restricted Share Units and 367,815 share options, signaling increased insider alignment.
NASDAQ
COMPASS Pathways' Chief Medical Officer, Guy Goodwin, acquired 170,600 stock options with varying exercise prices and vesting schedules.
NASDAQ
COMPASS Pathways plc's Chief Financial Officer, Teri Loxam, received significant equity awards, including Restricted Share Units and stock options, on March 26, 2026.
NASDAQ
COMPASS Pathways plc CEO Kabir Nath disposed of 13,131 ordinary shares to cover tax withholding obligations related to restricted share unit vesting.
NASDAQ
COMPASS Pathways CFO Teri Loxam reported a disposition of 1,781 ordinary shares for tax withholding purposes following restricted share unit vesting.
NASDAQ
COMPASS Pathways plc's Chief Financial Officer, Teri Loxam, disposed of 4,467 ordinary shares at $7.02 each to cover tax withholding obligations related to restricted share unit vesting.
NASDAQ
COMPASS Pathways plc CEO Kabir Nath reported the disposal of 16,181 ordinary shares to cover tax obligations related to restricted share unit vesting.
NASDAQ
Jeffrey M. Jonas, a Director at COMPASS Pathways plc, was granted 52,000 share options with an exercise price of $6.33, vesting over three years.
NASDAQ
COMPASS Pathways plc CEO Kabir Nath reported the disposition of 6,366 ordinary shares to cover tax obligations related to restricted share unit vesting.
NASDAQ
COMPASS Pathways plc Director Justin Gover was granted 52,000 share options with an exercise price of $4.29, vesting over three years.
NASDAQ
Form 4: COMPASS Pathways Director Acquires 39,000 Share Options, Aligning Interests with Future Growth
Gino Santini, a Director at COMPASS Pathways plc, has acquired 39,000 share options with an exercise price of $4.52, vesting fully by June 2026 or the 2026 Annual General Meeting.
NASDAQ
COMPASS Pathways plc Director Wayne Joseph Riley was granted 26,000 share options with an exercise price of $4.52, vesting by June 2026.
NASDAQ
David Y Norton, a Director of COMPASS Pathways plc, has been granted 26,000 share options with an exercise price of $4.52, vesting by June 2026.
NASDAQ
COMPASS Pathways plc Director Robert McQuade was granted 26,000 share options with an exercise price of $4.52, aligning his interests with shareholders.
NASDAQ
COMPASS Pathways plc Director Linda McGoldrick was granted 26,000 share options with an exercise price of $4.52, vesting by June 2026.
NASDAQ
Thomas Lonngren, a Director at COMPASS Pathways plc, was granted 26,000 share options with an exercise price of $4.52, vesting by June 2026.
NASDAQ
Daphne Karydas, a Director at COMPASS Pathways plc, acquired 26,000 share options with an exercise price of $4.52, vesting by June 2026.
NASDAQ
COMPASS Pathways plc Director Annalisa Jenkins has been granted 26,000 share options at an exercise price of $4.52, aligning her interests with shareholders.
NASDAQ
Guy Goodwin, Chief Medical Officer of Compass Pathways PLC, reports the acquisition of share options.
NASDAQ
Teri Loxam, CFO of Compass Pathways, reports the acquisition of 25,000 restricted share units and 76,000 share options.
NASDAQ
CEO Kabir Nath reports acquisition of shares and options in Compass Pathways plc.
NASDAQ
Teri Loxam, CFO of Compass Pathways plc, reports the disposal of shares to cover tax withholding obligations upon vesting of restricted share units.